Exact Mass: 304.9526
Exact Mass Matches: 304.9526
Found 85 metabolites which its exact mass value is equals to given mass value 304.9526
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clioquinol
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AA - Hydroxyquinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C254 - Anti-Infective Agent
5-[(E)-(6-Bromo-1H-indole-3-yl)methylene]imidazolidine-2,4-dione
clioquinol
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases > P01AA - Hydroxyquinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C254 - Anti-Infective Agent
Acetamide,2,2,2-trichloro-N-[3-(trifluoromethyl)phenyl]-
Sodium risedronate
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt
2-Methyl-2-propanyl (2-bromo-4-chlorophenyl)carbamate
4-(2-PYRIDINYLOXY)BENZENESULFONYLCHLORIDEHYDROCHLORIDE
ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE
3-bromo-7-pyridin-3-ylthieno[3,2-c]pyridin-4-amine
4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl chloride
6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine
ETHYL 2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE-4-CARBOXYLATE
ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE
3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol
4-(Pyridin-3-yloxy)benzene-1-sulfonyl chloride hydrochloride
2-(5-BROMO-THIOPHEN-2-YL)-2,3-DIHYDRO-BENZOFURAN-5-CARBONITRILE
5-Bromo-2-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
2-Bromo-6-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
2-(2,6-DICHLOROBENZYL)THIAZOLE-4-CARBONYL CHLORIDE
Iodohippuric acid i-131
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
2-(2,3,3-Trichloro-1-nitroprop-2-enylidene)-1,3-dihydrobenzimidazole
alpha-D-ribose 1-methylphosphonate 5-phosphate(3-)
2-(5-Bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one
5-chloro-7-iodoquinolin-8-ol
A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimers disease.
Taminadenant
Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].